World's Best Scientists 2026 revealed!
VIEW LIST
Joyce O'Shaughnessy

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Medicine 97 9062 8505 4674 4322 751 65637

Joyce O'Shaughnessy publications per year

The chart shows the history of publications by Joyce O'Shaughnessy between 1987 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Joyce O'Shaughnessy published across 39 years, from 1987 to 2025, averaging 21.5 papers a year. Output peaked at 70 publications in 2021. 103 of the 838 publications appeared in the last two years.

No. of publications
20 40 60
Bar chart. Horizontal axis: year, 1987 to 2025. Vertical axis: number of publications, 0 to 70. Peak 70 publications in 2021. 1987: 1 publication 1988: 0 publications 1989: 0 publications 1990: 0 publications 1991: 1 publication 1992: 0 publications 1993: 6 publications 1994: 5 publications 1995: 5 publications 1996: 7 publications 1997: 1 publication 1998: 3 publications 1999: 3 publications 2000: 3 publications 2001: 9 publications 2002: 26 publications 2003: 26 publications 2004: 13 publications 2005: 25 publications 2006: 16 publications 2007: 15 publications 2008: 16 publications 2009: 28 publications 2010: 24 publications 2011: 33 publications 2012: 24 publications 2013: 30 publications 2014: 31 publications 2015: 41 publications 2016: 32 publications 2017: 43 publications 2018: 33 publications 2019: 37 publications 2020: 55 publications 2021: 70 publications 2022: 13 publications 2023: 60 publications 2024: 65 publications 2025: 38 publications
1987 2025

838 publications in total across all disciplines

View publications per year as a table
Joyce O'Shaughnessy: publications per year, 1987 to 2025
Year Publications
1987 1
1988 0
1989 0
1990 0
1991 1
1992 0
1993 6
1994 5
1995 5
1996 7
1997 1
1998 3
1999 3
2000 3
2001 9
2002 26
2003 26
2004 13
2005 25
2006 16
2007 15
2008 16
2009 28
2010 24
2011 33
2012 24
2013 30
2014 31
2015 41
2016 32
2017 43
2018 33
2019 37
2020 55
2021 70
2022 13
2023 60
2024 65
2025 38
Total 838
Download as CSV

Joyce O'Shaughnessy publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Joyce O'Shaughnessy sits on this spectrum.

No. of scientists
200 400 600 800
Bar chart with 86 bars. Horizontal axis: publications, 101–120 to 1,796+. Vertical axis: number of scientists, 0 to 922. Most scientists, 922, have 341–360 publications. The last bar groups every scientist with 1,796 publications or more. The highlighted bar, 741–760 publications, is where this scientist sits. 101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101–120 publications 1,796+

This scientist: 751 publications — 84th percentile

84% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

View publications distribution as a table
Number of Medicine scientists by publication count, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
Publications Scientists This scientist
101–120 5
121–140 26
141–160 73
161–180 155
181–200 230
201–220 363
221–240 487
241–260 545
261–280 722
281–300 768
301–320 834
321–340 895
341–360 922
361–380 838
381–400 861
401–420 918
421–440 806
441–460 771
461–480 751
481–500 713
501–520 617
521–540 610
541–560 537
561–580 504
581–600 509
601–620 396
621–640 386
641–660 371
661–680 340
681–700 336
701–720 307
721–740 259
741–760 230 751
761–780 228
781–800 217
801–820 204
821–840 186
841–860 177
861–880 155
881–900 139
901–920 145
921–940 116
941–960 133
961–980 91
981–1,000 96
1,001–1,020 77
1,021–1,040 70
1,041–1,060 63
1,061–1,080 77
1,081–1,100 49
1,101–1,120 54
1,121–1,140 49
1,141–1,160 51
1,161–1,180 35
1,181–1,200 39
1,201–1,220 26
1,221–1,240 37
1,241–1,260 36
1,261–1,280 27
1,281–1,300 32
1,301–1,320 28
1,321–1,340 17
1,341–1,360 30
1,361–1,380 28
1,381–1,400 17
1,401–1,420 21
1,421–1,440 15
1,441–1,460 12
1,461–1,480 12
1,481–1,500 18
1,501–1,520 14
1,521–1,540 17
1,541–1,560 15
1,561–1,580 6
1,581–1,600 2
1,601–1,620 12
1,621–1,640 11
1,641–1,660 8
1,661–1,680 5
1,681–1,700 5
1,701–1,720 10
1,721–1,740 12
1,741–1,760 14
1,761–1,780 6
1,781–1,795 5
1,796+ 100
Download as CSV

Joyce O'Shaughnessy D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Joyce O'Shaughnessy sits on this spectrum.

No. of scientists
250 500 750 1,000
Bar chart with 75 bars. Horizontal axis: D-Index, 70–71 to 217+. Vertical axis: number of scientists, 0 to 1,027. Most scientists, 1,027, have 82–83 D-Index. The last bar groups every scientist with 217 D-Index or more. The highlighted bar, 96–97 D-Index, is where this scientist sits. 70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70–71 D-Index 217+

This scientist: 97 D-Index — 55th percentile

55% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

View D-Index distribution as a table
Number of Medicine scientists by D-index, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
D-Index Scientists This scientist
70–71 226
72–73 391
74–75 574
76–77 730
78–79 891
80–81 972
82–83 1,027
84–85 1,003
86–87 960
88–89 970
90–91 922
92–93 839
94–95 808
96–97 779 97
98–99 668
100–101 611
102–103 630
104–105 513
106–107 541
108–109 445
110–111 429
112–113 399
114–115 393
116–117 318
118–119 302
120–121 287
122–123 255
124–125 256
126–127 252
128–129 230
130–131 179
132–133 168
134–135 163
136–137 159
138–139 134
140–141 134
142–143 118
144–145 109
146–147 106
148–149 74
150–151 79
152–153 80
154–155 87
156–157 57
158–159 74
160–161 69
162–163 60
164–165 53
166–167 39
168–169 42
170–171 32
172–173 39
174–175 40
176–177 28
178–179 19
180–181 23
182–183 31
184–185 18
186–187 20
188–189 22
190–191 13
192–193 21
194–195 12
196–197 12
198–199 14
200–201 15
202–203 13
204–205 10
206–207 8
208–209 4
210–211 12
212–213 11
214–215 10
216 4
217+ 98
Download as CSV

Overview

Joyce O'Shaughnessy is affiliated with Baylor University Medical Center in the United States. Their research primarily falls within the field of Medicine, with a focus on Oncology and several related subfields, including Pulmonary and Respiratory Medicine, Cancer Research, Radiology, Nuclear Medicine and Imaging, and Genetics.

Their work covers a range of topics in cancer research, emphasizing:

  • Advanced Breast Cancer Therapies
  • HER2/EGFR in Cancer Research
  • Breast Cancer Treatment Studies
  • Cancer Treatment and Pharmacology
  • Cancer Immunotherapy and Biomarkers
  • Monoclonal and Polyclonal Antibodies Research
  • Cancer-related Molecular Pathways

Frequent publication venues for Joyce O'Shaughnessy include:

  • Cancer Research
  • Annals of Oncology
  • Journal of Clinical Oncology
  • Clinical Cancer Research
  • New England Journal of Medicine

They have collaborated extensively with co-authors such as Hope S. Rugo, Javier Cortés, Nadia Harbeck, Sara M. Tolaney, and Sara A. Hurvitz, with collaboration counts ranging from 23 to 36 joint works.

Recent notable publications include:

  • Pembrolizumab for Early Triple-Negative Breast Cancer, 2020, New England Journal of Medicine
  • Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer, 2021, New England Journal of Medicine
  • Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer, 2021, Annals of Oncology
  • Sacituzumab govitecan, a Trop-2-directed antibody-drug conjugate, for patients with epithelial cancer: final safety and efficacy results from the phase I/II IMMU-132-01 basket trial, 2021, Annals of Oncology
  • Overall Survival with Pembrolizumab in Early-Stage Triple-Negative Breast Cancer, 2024, New England Journal of Medicine

Their publications have attracted significant citations, indicating the impact and reach of their recent work in the oncology and breast cancer research communities.

Best Publications

  • Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

    O. Abe;R. Abe;K. Enomoto;K. Kikuchi

  • Phase III Trial of Nanoparticle Albumin-Bound Paclitaxel Compared With Polyethylated Castor Oil–Based Paclitaxel in Women With Breast Cancer

    William J. Gradishar;Sergei Tjulandin;Neville Davidson;Heather Shaw

  • Pembrolizumab for Early Triple-Negative Breast Cancer.

    Peter Schmid;Javier Cortes;Lajos Pusztai;Heather McArthur

  • Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer

    Gabriel N. Hortobagyi;Salomon M. Stemmer;Howard A. Burris;Yoon-Sim Yap

  • RIBBON-1: Randomized, Double-Blind, Placebo-Controlled, Phase III Trial of Chemotherapy With or Without Bevacizumab for First-Line Treatment of Human Epidermal Growth Factor Receptor 2–Negative, Locally Recurrent or Metastatic Breast Cancer

    Nicholas J. Robert;Véronique Diéras;John Glaspy;Adam M. Brufsky

  • Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer

    Aditya Bardia;Sara A Hurvitz;Sara M Tolaney;Delphine Loirat

  • Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): A phase 3 open-label randomised study

    Javier Cortes;Joyce O'Shaughnessy;David Loesch;Joanne J.L. Blum

  • Randomized Study of Lapatinib Alone or in Combination With Trastuzumab in Women With ErbB2-Positive, Trastuzumab-Refractory Metastatic Breast Cancer

    Kimberly L. Blackwell;Harold J. Burstein;Anna Maria Storniolo;Hope Rugo

  • Phase II Study of the Antibody Drug Conjugate Trastuzumab-DM1 for the Treatment of Human Epidermal Growth Factor Receptor 2 (HER2) –Positive Breast Cancer After Prior HER2-Directed Therapy

    Howard A. Burris;Hope S. Rugo;Svetislava J. Vukelja;Charles L. Vogel

  • Sacituzumab Govitecan-hziy in Refractory Metastatic Triple-Negative Breast Cancer.

    Aditya Bardia;Ingrid A Mayer;Linda T Vahdat;Sara M Tolaney

  • Progress and Promise of FDG-PET Imaging for Cancer Patient Management and Oncologic Drug Development

    Gary J. Kelloff;John M. Hoffman;Bruce Johnson;Howard I. Scher

  • The Global Breast Cancer Burden: Variations in Epidemiology and Survival

    Gabriel N. Hortobagyi;Jaime de la Garza Salazar;Kathleen Pritchard;Dino Amadori

  • Updated results from MONALEESA-2, a phase III trial of first-line ribociclib plus letrozole versus placebo plus letrozole in hormone receptor-positive, HER2-negative advanced breast cancer.

    Gabriel N. Hortobagyi;Salomon M. Stemmer;Howard A. Burris;Yoon-Sim Yap

  • Addition of the PARP inhibitor veliparib plus carboplatin or carboplatin alone to standard neoadjuvant chemotherapy in triple-negative breast cancer (BrighTNess): a randomised, phase 3 trial

    Sibylle Loibl;Joyce O'Shaughnessy;Michael Untch;William M Sikov

  • Detection of Chromosomal Alterations in the Circulation of Cancer Patients with Whole-Genome Sequencing

    Rebecca J. Leary;Mark Sausen;Isaac Kinde;Nickolas Papadopoulos

  • Blinded, Randomized, Multicenter Study to Evaluate Single Administration Pegfilgrastim Once per Cycle Versus Daily Filgrastim as an Adjunct to Chemotherapy in Patients With High-Risk Stage II or Stage III/IV Breast Cancer

    F.A. Holmes;J.A. O’Shaughnessy;S. Vukelja;S.E. Jones

  • Overall Survival Benefit With Lapatinib in Combination With Trastuzumab for Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer: Final Results From the EGF104900 Study

    Kimberly L. Blackwell;Harold J. Burstein;Anna Maria Storniolo;Hope S. Rugo

  • Phase III Trial Comparing Doxorubicin Plus Cyclophosphamide With Docetaxel Plus Cyclophosphamide As Adjuvant Therapy for Operable Breast Cancer

    Stephen E. Jones;Michael A. Savin;Frankie Ann Holmes;Joyce A. O'Shaughnessy

  • A Genomic Predictor of Response and Survival Following Taxane-Anthracycline Chemotherapy for Invasive Breast Cancer

    Christos Hatzis;Lajos Pusztai;Vicente Valero;Daniel J. Booser

  • Pembrolizumab monotherapy for previously treated metastatic triple-negative breast cancer: cohort A of the phase II KEYNOTE-086 study.

    Sylvia Adams;Peter Schmid;Hope H.S. Rugo;Eric Winer

Frequent Co-Authors

Hope S. Rugo
Hope S. Rugo University of California, San Francisco
Javier Cortes
Javier Cortes Vall d'Hebron Hospital Universitari
Adam Brufsky
Adam Brufsky University of Pittsburgh
Aditya Bardia
Aditya Bardia Harvard University
Nadia Harbeck
Nadia Harbeck Ludwig-Maximilians-Universität München
Véronique Diéras
Véronique Diéras Institute Curie
Sara A. Hurvitz
Sara A. Hurvitz Fred Hutchinson Cancer Research Center
Sara M. Tolaney
Sara M. Tolaney Harvard University
Michael Untch
Michael Untch Helios Klinikum Berlin-Buch
Igor Bondarenko
Igor Bondarenko Ministry of Internal Affairs

External Links

Personal website of Joyce O'Shaughnessy

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

The journey to a healthcare career in the USA offers various alternative pathways beyond a traditional MD. Many students consider advanced nursing degrees, especially programs tailored for non-nurses. For those interested in accelerated options, direct entry msn programs for non-nurses online can be an excellent choice, helping you transition into nursing with a master’s degree even if your background isn’t in healthcare.

Admissions requirements vary widely among schools. Some prospective students search for whats the easiest nursing program to get into? to increase their chances of enrolling quickly, especially if they wish to enter the workforce soon. Similarly, students looking to avoid standardized entrance exams can explore institutions listed in do all nursing schools require the teas.

For those interested in allied health, medical billing and coding is a fast-growing field that provides remote career opportunities. The best medical billing and coding schools online offer accredited programs, often with financial aid, that make it easier to start a healthcare career from home. These diverse pathways make it possible to find a medical or healthcare career that fits your background and life goals.

Best Scientists Citing Joyce O'Shaughnessy

Giuseppe Curigliano

Giuseppe Curigliano

University of Milan

Publications: 102

Javier Cortes

Javier Cortes

Vall d'Hebron Hospital Universitari

Publications: 95

Eric P. Winer

Eric P. Winer

Yale University

Publications: 86

Hope S. Rugo

Hope S. Rugo

University of California, San Francisco

Publications: 86

Andreas Schneeweiss

Andreas Schneeweiss

German Cancer Research Center

Publications: 82

Nadia Harbeck

Nadia Harbeck

Ludwig-Maximilians-Universität München

Publications: 82

Evandro de Azambuja

Evandro de Azambuja

Université Libre de Bruxelles

Publications: 72

Martine Piccart

Martine Piccart

Université Libre de Bruxelles

Publications: 67

Sherene Loi

Sherene Loi

Peter MacCallum Cancer Centre

Publications: 67

Peter A. Fasching

Peter A. Fasching

University of Erlangen-Nuremberg

Publications: 67

Gabriel N. Hortobagyi

Gabriel N. Hortobagyi

The University of Texas MD Anderson Cancer Center

Publications: 65

Lajos Pusztai

Lajos Pusztai

Yale University

Publications: 65

Miguel Martin

Miguel Martin

Complutense University of Madrid

Publications: 63

Sibylle Loibl

Sibylle Loibl

Goethe University Frankfurt

Publications: 62

Sara M. Tolaney

Sara M. Tolaney

Harvard University

Publications: 61

Mario Campone

Mario Campone

Grenoble Alpes University

Publications: 61

Trending Scientists

Kiyoshi Hirao

Kiyoshi Hirao

National Institute of Advanced Industrial Science and Technology

Praphathip Eamsobhana

Praphathip Eamsobhana

Mahidol University

Thomas Benfield

Thomas Benfield

Copenhagen University Hospital

Wilf Powell

Wilf Powell

Rothamsted Research

K. Eric Wommack

K. Eric Wommack

University of Delaware

Matthieu Piel

Matthieu Piel

Institute Curie

Wei Wang

Wei Wang

Chinese Academy of Sciences

Jimmy Ba

Jimmy Ba

University of Toronto

Nauman Aslam

Nauman Aslam

Northumbria University

Malcolm M Feeley

Malcolm M Feeley

University of California, Berkeley

Gonzalo Jiménez-Osés

Gonzalo Jiménez-Osés

Ikerbasque

Jikun Huang

Jikun Huang

Peking University

Axel R. Zander

Axel R. Zander

Huntsman Cancer Institute

Louis J. Billera

Louis J. Billera

Cornell University

Bradley J. Peterson

Bradley J. Peterson

Stony Brook University

Jan Beck

Jan Beck

University of Colorado Boulder

Related Medicine Rankings & Guides

2027 Healthcare Administration Degree Guide: Costs, Requirements & Job Opportunities

2027 Healthcare Administration Degree Guide: Costs, Requirements & Job Opportunities
2027 Best Pharmacy Schools & Pharmacist Programs Requirements in Oklahoma: Online & Campus

2027 Best Pharmacy Schools & Pharmacist Programs Requirements in Oklahoma: Online & Campus
2027 Best Online CAHME-Accredited MHA Programs

2027 Best Online CAHME-Accredited MHA Programs
2027 Best Online MSN in Health/Nursing Informatics Programs

2027 Best Online MSN in Health/Nursing Informatics Programs
2027 Cheapest Online Nursing Informatics Degree Programs

2027 Cheapest Online Nursing Informatics Degree Programs
2027 Easiest Direct-Entry MSN Programs to Get Into

2027 Easiest Direct-Entry MSN Programs to Get Into
2027 Best Nurse Practitioner Programs in Mississippi – Accredited Schools Online & Campus

2027 Best Nurse Practitioner Programs in Mississippi – Accredited Schools Online & Campus
2027 Best Self-Paced Online RN-to-BSN Degree Programs

2027 Best Self-Paced Online RN-to-BSN Degree Programs
2027 Fastest Doctor of Nursing Practice (DNP) Degree Programs

2027 Fastest Doctor of Nursing Practice (DNP) Degree Programs
2027 Fastest Online BSN to MSN Bridge Programs

2027 Fastest Online BSN to MSN Bridge Programs
2027 Best Online Exercise Science Degree Programs

2027 Best Online Exercise Science Degree Programs
2027 Easiest DNP Programs

2027 Easiest DNP Programs
2027 Best Nurse Practitioner Programs in Oklahoma – Accredited Schools Online & Campus

2027 Best Nurse Practitioner Programs in Oklahoma – Accredited Schools Online & Campus
2027 Best Nurse Practitioner Programs in South Carolina – Accredited Schools Online & Campus

2027 Best Nurse Practitioner Programs in South Carolina – Accredited Schools Online & Campus
2027 Best Nurse Practitioner Programs in Wisconsin – Accredited Schools Online & Campus

2027 Best Nurse Practitioner Programs in Wisconsin – Accredited Schools Online & Campus
2027 Best Online Respiratory Therapy Programs

2027 Best Online Respiratory Therapy Programs
2027 Best Online FNP Programs That Provide Preceptors

2027 Best Online FNP Programs That Provide Preceptors
2027 Best One-Year Online PMHNP Programs

2027 Best One-Year Online PMHNP Programs
2027 Best Online BSN to FNP Programs

2027 Best Online BSN to FNP Programs
2027 Best Nurse Practitioner Programs in Indiana – Accredited Schools Online & Campus

2027 Best Nurse Practitioner Programs in Indiana – Accredited Schools Online & Campus
2027 Best Online Medical & Healthcare Certificate Programs

2027 Best Online Medical & Healthcare Certificate Programs

Recently Published Articles

2027 Is a 2-Year Respiratory Care Therapy Degree Worth It: Accelerated Bachelor's ROI & Time Trade-Offs

2027 Is a 2-Year Respiratory Care Therapy Degree Worth It: Accelerated Bachelor's ROI & Time Trade-Offs
2027 Online MBA Programs That Accept Low GPA Applicants

2027 Online MBA Programs That Accept Low GPA Applicants
2027 How to Become a Caregiver: Certification Requirements in Kentucky

2027 How to Become a Caregiver: Certification Requirements in Kentucky
2027 Best Online Biostatistics Degree Master's Programs for Working Professionals

2027 Best Online Biostatistics Degree Master's Programs for Working Professionals
2027 Hardest and Easiest Courses in an Environmental Science Degree Program

2027 Hardest and Easiest Courses in an Environmental Science Degree Program
2027 Licensing Exams Required After Completing a Science Degree Program

2027 Licensing Exams Required After Completing a Science Degree Program
2027 Fastest Online Graduate Certificate Programs in Early Childhood Education

2027 Fastest Online Graduate Certificate Programs in Early Childhood Education
2027 Best Healthcare Administration Certifications to Consider

2027 Best Healthcare Administration Certifications to Consider
2027 Is Demand for Health Sciences Degree Graduates Growing or Declining?

2027 Is Demand for Health Sciences Degree Graduates Growing or Declining?
2027 Do Online Healthcare Management Programs Offer Weekly Start Dates? Enrollment Calendar & Start Options

2027 Do Online Healthcare Management Programs Offer Weekly Start Dates? Enrollment Calendar & Start Options
2027 Cheapest Online Biomedical Sciences Master's Degrees That Pay Well: Tuition, Duration, and Earnings

2027 Cheapest Online Biomedical Sciences Master's Degrees That Pay Well: Tuition, Duration, and Earnings
2027 Associate to Bachelor's in Construction Management: Transfer Pathways Explained

2027 Associate to Bachelor's in Construction Management: Transfer Pathways Explained
2027 Are There Any One-Year Online Software Development Degree Programs Worth Considering?

2027 Are There Any One-Year Online Software Development Degree Programs Worth Considering?
2027 Pre-Nursing vs. Nursing Majors: Explaining the Difference

2027 Pre-Nursing vs. Nursing Majors: Explaining the Difference
2027 What Can You Do with a Social Work Master's Degree? Careers, Salaries & Growth

2027 What Can You Do with a Social Work Master's Degree? Careers, Salaries & Growth
2027 AI Master's Degrees That Include Recommendation Systems

2027 AI Master's Degrees That Include Recommendation Systems
2027 Best Online Physical Education Programs

2027 Best Online Physical Education Programs
2027 Hardest and Easiest Courses in an Education Degree Program

2027 Hardest and Easiest Courses in an Education Degree Program
2027 How to Become a Curriculum Developer: Education, Salary, and Job Outlook

2027 How to Become a Curriculum Developer: Education, Salary, and Job Outlook
2027 How to Become a Mental Health Counselor in Nebraska

2027 How to Become a Mental Health Counselor in Nebraska
2027 Best Advanced Standing Online MSW Programs [CSWE Accredited]

2027 Best Advanced Standing Online MSW Programs [CSWE Accredited]